Cargando…
Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study
BACKGROUND: Shared decision making (SDM) implementation remains challenging. The factors that promote or hinder implementation of SDM tools for use during the consultation, including contextual factors such as clinician burnout and organizational support, remain unclear. We explored these factors in...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218532/ https://www.ncbi.nlm.nih.gov/pubmed/32398149 http://dx.doi.org/10.1186/s13063-020-04305-2 |
_version_ | 1783532817152475136 |
---|---|
author | Spencer-Bonilla, Gabriela Thota, Anjali Organick, Paige Ponce, Oscar J. Kunneman, Marleen Giblon, Rachel Branda, Megan E. Sivly, Angela L. Behnken, Emma May, Carl R. Montori, Victor M. |
author_facet | Spencer-Bonilla, Gabriela Thota, Anjali Organick, Paige Ponce, Oscar J. Kunneman, Marleen Giblon, Rachel Branda, Megan E. Sivly, Angela L. Behnken, Emma May, Carl R. Montori, Victor M. |
author_sort | Spencer-Bonilla, Gabriela |
collection | PubMed |
description | BACKGROUND: Shared decision making (SDM) implementation remains challenging. The factors that promote or hinder implementation of SDM tools for use during the consultation, including contextual factors such as clinician burnout and organizational support, remain unclear. We explored these factors in the context of a practical multicenter randomized trial evaluating the effectiveness of an SDM conversation tool for patients with atrial fibrillation considering anticoagulation therapy. METHODS: In this cross-sectional study, we recruited clinicians who were regularly involved in conversations with patients regarding anticoagulation for atrial fibrillation. Clinicians reported their characteristics and burnout symptoms using the two-item Maslach Burnout Inventory. Clinicians were trained in using the SDM tool, and they recorded their perceptions of the tool’s normalization potential using the Normalization MeAsure Development (NoMAD) survey instrument and verbally reflected on their answers to these survey questions. When possible, the training sessions and clinicians’ verbal responses to the conversation tool were recorded. RESULTS: Our study comprised 183 clinicians recruited into the trial (168 with survey responses and 112 with recordings). Overall, clinicians gave high scores to the normalization potential of the intervention; they endorsed all domains of normalization to the same extent, regardless of site, clinician characteristics, or burnout ratings. In interviews, clinicians paid significant attention to making sense of the tool. Tool buy-in seemed to depend heavily on their ability to see the tool as accurate and “evidence-based” and their perceptions of having time in the consultation to use it. CONCLUSIONS: While time in the consultation remains a barrier, we did not find a significant association between burnout symptoms and normalization of an SDM conversation tool. Possible areas for improving the normalization of SDM conversation tools in clinical practice include enabling collaboration among clinicians to implement the tool and reporting how clinicians elsewhere use the tool. Direct measures of normalization (i.e., observing how often clinicians access the tool in practice outside of the clinical trial) may further elucidate the role that contextual factors, such as clinician burnout, play in the implementation of SDM. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02905032. Registered on 9 September 2016. |
format | Online Article Text |
id | pubmed-7218532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72185322020-05-18 Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study Spencer-Bonilla, Gabriela Thota, Anjali Organick, Paige Ponce, Oscar J. Kunneman, Marleen Giblon, Rachel Branda, Megan E. Sivly, Angela L. Behnken, Emma May, Carl R. Montori, Victor M. Trials Research BACKGROUND: Shared decision making (SDM) implementation remains challenging. The factors that promote or hinder implementation of SDM tools for use during the consultation, including contextual factors such as clinician burnout and organizational support, remain unclear. We explored these factors in the context of a practical multicenter randomized trial evaluating the effectiveness of an SDM conversation tool for patients with atrial fibrillation considering anticoagulation therapy. METHODS: In this cross-sectional study, we recruited clinicians who were regularly involved in conversations with patients regarding anticoagulation for atrial fibrillation. Clinicians reported their characteristics and burnout symptoms using the two-item Maslach Burnout Inventory. Clinicians were trained in using the SDM tool, and they recorded their perceptions of the tool’s normalization potential using the Normalization MeAsure Development (NoMAD) survey instrument and verbally reflected on their answers to these survey questions. When possible, the training sessions and clinicians’ verbal responses to the conversation tool were recorded. RESULTS: Our study comprised 183 clinicians recruited into the trial (168 with survey responses and 112 with recordings). Overall, clinicians gave high scores to the normalization potential of the intervention; they endorsed all domains of normalization to the same extent, regardless of site, clinician characteristics, or burnout ratings. In interviews, clinicians paid significant attention to making sense of the tool. Tool buy-in seemed to depend heavily on their ability to see the tool as accurate and “evidence-based” and their perceptions of having time in the consultation to use it. CONCLUSIONS: While time in the consultation remains a barrier, we did not find a significant association between burnout symptoms and normalization of an SDM conversation tool. Possible areas for improving the normalization of SDM conversation tools in clinical practice include enabling collaboration among clinicians to implement the tool and reporting how clinicians elsewhere use the tool. Direct measures of normalization (i.e., observing how often clinicians access the tool in practice outside of the clinical trial) may further elucidate the role that contextual factors, such as clinician burnout, play in the implementation of SDM. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02905032. Registered on 9 September 2016. BioMed Central 2020-05-12 /pmc/articles/PMC7218532/ /pubmed/32398149 http://dx.doi.org/10.1186/s13063-020-04305-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Spencer-Bonilla, Gabriela Thota, Anjali Organick, Paige Ponce, Oscar J. Kunneman, Marleen Giblon, Rachel Branda, Megan E. Sivly, Angela L. Behnken, Emma May, Carl R. Montori, Victor M. Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study |
title | Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study |
title_full | Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study |
title_fullStr | Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study |
title_full_unstemmed | Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study |
title_short | Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study |
title_sort | normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218532/ https://www.ncbi.nlm.nih.gov/pubmed/32398149 http://dx.doi.org/10.1186/s13063-020-04305-2 |
work_keys_str_mv | AT spencerbonillagabriela normalizationofaconversationtooltopromoteshareddecisionmakingaboutanticoagulationinpatientswithatrialfibrillationwithinapracticalrandomizedtrialofitseffectivenessacrosssectionalstudy AT thotaanjali normalizationofaconversationtooltopromoteshareddecisionmakingaboutanticoagulationinpatientswithatrialfibrillationwithinapracticalrandomizedtrialofitseffectivenessacrosssectionalstudy AT organickpaige normalizationofaconversationtooltopromoteshareddecisionmakingaboutanticoagulationinpatientswithatrialfibrillationwithinapracticalrandomizedtrialofitseffectivenessacrosssectionalstudy AT ponceoscarj normalizationofaconversationtooltopromoteshareddecisionmakingaboutanticoagulationinpatientswithatrialfibrillationwithinapracticalrandomizedtrialofitseffectivenessacrosssectionalstudy AT kunnemanmarleen normalizationofaconversationtooltopromoteshareddecisionmakingaboutanticoagulationinpatientswithatrialfibrillationwithinapracticalrandomizedtrialofitseffectivenessacrosssectionalstudy AT giblonrachel normalizationofaconversationtooltopromoteshareddecisionmakingaboutanticoagulationinpatientswithatrialfibrillationwithinapracticalrandomizedtrialofitseffectivenessacrosssectionalstudy AT brandamegane normalizationofaconversationtooltopromoteshareddecisionmakingaboutanticoagulationinpatientswithatrialfibrillationwithinapracticalrandomizedtrialofitseffectivenessacrosssectionalstudy AT sivlyangelal normalizationofaconversationtooltopromoteshareddecisionmakingaboutanticoagulationinpatientswithatrialfibrillationwithinapracticalrandomizedtrialofitseffectivenessacrosssectionalstudy AT behnkenemma normalizationofaconversationtooltopromoteshareddecisionmakingaboutanticoagulationinpatientswithatrialfibrillationwithinapracticalrandomizedtrialofitseffectivenessacrosssectionalstudy AT maycarlr normalizationofaconversationtooltopromoteshareddecisionmakingaboutanticoagulationinpatientswithatrialfibrillationwithinapracticalrandomizedtrialofitseffectivenessacrosssectionalstudy AT montorivictorm normalizationofaconversationtooltopromoteshareddecisionmakingaboutanticoagulationinpatientswithatrialfibrillationwithinapracticalrandomizedtrialofitseffectivenessacrosssectionalstudy AT normalizationofaconversationtooltopromoteshareddecisionmakingaboutanticoagulationinpatientswithatrialfibrillationwithinapracticalrandomizedtrialofitseffectivenessacrosssectionalstudy |